Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Phosphofructokinases A and B from Mycobacterium tuberculosis Display Different Catalytic Properties and Allosteric Regulation

J. Snášel, I. Machová, V. Šolínová, V. Kašička, M. Krečmerová, I. Pichová

. 2021 ; 22 (3) : . [pub] 20210202

Jazyk angličtina Země Švýcarsko

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019288

Grantová podpora
CZ.02.1.01/0.0/16_019/000729 Ministerstvo Školství, Mládeže a Tělovýchovy
RVO 61388963 Akademie Věd České Republiky

Tuberculosis (TB) remains one of the major health concerns worldwide. Mycobacterium tuberculosis (Mtb), the causative agent of TB, can flexibly change its metabolic processes during different life stages. Regulation of key metabolic enzyme activities by intracellular conditions, allosteric inhibition or feedback control can effectively contribute to Mtb survival under different conditions. Phosphofructokinase (Pfk) is one of the key enzymes regulating glycolysis. Mtb encodes two Pfk isoenzymes, Pfk A/Rv3010c and Pfk B/Rv2029c, which are differently expressed upon transition to the hypoxia-induced non-replicating state of the bacteria. While pfkB gene and protein expression are upregulated under hypoxic conditions, Pfk A levels decrease. Here, we present biochemical characterization of both Pfk isoenzymes, revealing that Pfk A and Pfk B display different kinetic properties. Although the glycolytic activity of Pfk A is higher than that of Pfk B, it is markedly inhibited by an excess of both substrates (fructose-6-phosphate and ATP), reaction products (fructose-1,6-bisphosphate and ADP) and common metabolic allosteric regulators. In contrast, synthesis of fructose-1,6-bisphosphatase catalyzed by Pfk B is not regulated by higher levels of substrates, and metabolites. Importantly, we found that only Pfk B can catalyze the reverse gluconeogenic reaction. Pfk B thus can support glycolysis under conditions inhibiting Pfk A function.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019288
003      
CZ-PrNML
005      
20210830100852.0
007      
ta
008      
210728s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms22031483 $2 doi
035    __
$a (PubMed)33540748
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Snášel, Jan $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
245    10
$a Phosphofructokinases A and B from Mycobacterium tuberculosis Display Different Catalytic Properties and Allosteric Regulation / $c J. Snášel, I. Machová, V. Šolínová, V. Kašička, M. Krečmerová, I. Pichová
520    9_
$a Tuberculosis (TB) remains one of the major health concerns worldwide. Mycobacterium tuberculosis (Mtb), the causative agent of TB, can flexibly change its metabolic processes during different life stages. Regulation of key metabolic enzyme activities by intracellular conditions, allosteric inhibition or feedback control can effectively contribute to Mtb survival under different conditions. Phosphofructokinase (Pfk) is one of the key enzymes regulating glycolysis. Mtb encodes two Pfk isoenzymes, Pfk A/Rv3010c and Pfk B/Rv2029c, which are differently expressed upon transition to the hypoxia-induced non-replicating state of the bacteria. While pfkB gene and protein expression are upregulated under hypoxic conditions, Pfk A levels decrease. Here, we present biochemical characterization of both Pfk isoenzymes, revealing that Pfk A and Pfk B display different kinetic properties. Although the glycolytic activity of Pfk A is higher than that of Pfk B, it is markedly inhibited by an excess of both substrates (fructose-6-phosphate and ATP), reaction products (fructose-1,6-bisphosphate and ADP) and common metabolic allosteric regulators. In contrast, synthesis of fructose-1,6-bisphosphatase catalyzed by Pfk B is not regulated by higher levels of substrates, and metabolites. Importantly, we found that only Pfk B can catalyze the reverse gluconeogenic reaction. Pfk B thus can support glycolysis under conditions inhibiting Pfk A function.
650    _2
$a adenosindifosfát $x metabolismus $x farmakologie $7 D000244
650    _2
$a adenosintrifosfát $x metabolismus $x farmakologie $7 D000255
650    _2
$a alosterická regulace $7 D000494
650    _2
$a bakteriální proteiny $x antagonisté a inhibitory $x metabolismus $7 D001426
650    _2
$a katalýza $7 D002384
650    _2
$a enzymová indukce $7 D004790
650    _2
$a zpětná vazba fyziologická $7 D025461
650    _2
$a fruktosadifosfáty $x biosyntéza $x farmakologie $7 D005635
650    _2
$a fruktosafosfáty $x metabolismus $x farmakologie $7 D005636
650    _2
$a glukoneogeneze $7 D005943
650    _2
$a glykolýza $7 D006019
650    _2
$a hexosafosfáty $x metabolismus $7 D006600
650    _2
$a izoenzymy $x antagonisté a inhibitory $x metabolismus $7 D007527
650    _2
$a kinetika $7 D007700
650    _2
$a L-laktátdehydrogenasa $x metabolismus $7 D007770
650    _2
$a Mycobacterium tuberculosis $x účinky léků $x enzymologie $7 D009169
650    _2
$a kyslík $x farmakologie $7 D010100
650    _2
$a fosfofruktokinasy $x antagonisté a inhibitory $x metabolismus $7 D025221
650    _2
$a pyruvátkinasa $x metabolismus $7 D011770
650    _2
$a rekombinantní proteiny $x metabolismus $7 D011994
650    _2
$a substrátová specifita $7 D013379
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Machová, Iva $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
700    1_
$a Šolínová, Veronika $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
700    1_
$a Kašička, Václav $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
700    1_
$a Krečmerová, Marcela $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
700    1_
$a Pichová, Iva $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 16610 Prague 6, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 3 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33540748 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100852 $b ABA008
999    __
$a ok $b bmc $g 1690178 $s 1139734
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 22 $c 3 $e 20210202 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a CZ.02.1.01/0.0/16_019/000729 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a RVO 61388963 $p Akademie Věd České Republiky
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...